Home Tools
Log in
Cart

Search Result

Search Results for " plasma "

20

Compounds

Cat No. Product Name Synonyms Targets
T40312 Plasma kallikrein-IN-1
Plasma kallikrein-IN-1 is a PKK inhibitor with an IC 50 value of 0.5 nM.
T61403 Plasma kallikrein-IN-3
Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1].
T72337 Plasma kallikrein-IN-2
Plasma kallikrein-IN-2, a potent inhibitor of plasma kallikrein (PKal) with an inhibitory concentration (IC) 50 value of 0.1 nM, is utilized in research targeting hereditary angioedema, diabetic macular edema, and diabet...
T16369 O-Desmethyl gefitinib EGFR
O-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib. The formation of O-desmethyl gefitinib is dependent on the CYP2D6 acti...
T9215 ELOVL6-IN-2 Others
ELOVL6-IN-2 is a orally active and selective ELOVL6 inhibitor.
T26019 R59949 R-59949,R 59949 Others , PKC
R59949 is used as a Diacylglycerol kinase (DGK) inhibitor.
T34532 Sari 59-801 Sari-59-801 Others
Sari 59-801 is a novel, orally effective hypoglycemic compound.
T14984 CLP257 Potassium Channel
CLP257 is a selective K+-Cl− cotransporter KCC2 activator (EC50: 616 nM) and it is inactive against NKCC1, GABAA receptors, KCC1, KCC3 or KCC4. CLP257 alleviates hypersensitivity in rats with neuropathic painc and it al...
T8235 L-732138 Neurokinin receptor
L-732138 is a potent and competitive antagonist of neurokinin-1 (NK-1) receptor(IC50 : 2.3 nM)
T11793 KY-05009 Wnt/beta-catenin
KY-05009 is a chemical compound that effectively suppresses TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cells, reduces TNIK protein expression and the transcriptional activity o...
T1736 Apixaban BMS-562247-01 Factor Xa
Apixaban (BMS-562247-01) is an orally active inhibitor of coagulation factor Xa with anticoagulant activity. Apixaban directly inhibits factor Xa, thereby interfering with the conversion of prothrombin to thrombin and pr...
TP1158 Copper tripeptide GHK-Cu Others , Endogenous Metabolite
Copper tripeptide (GHK-Cu) is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The tripeptide has strong affinity for copper(II) and was first isolated from human plasma. It can be found...
T16075 (Rac)-Idroxioleic acid 2-Hydroxyoleic acid,2-OHOA,Minerval Apoptosis
(Rac)-Idroxioleic acid (2-Hydroxyoleic acid) is a fatty acid amide hydrolase inhibitor with anti-tumor effect. It binds to the plasma membrane and alters lipid organization.
T12146 N-Desmethyl-Apalutamide N-Desmethyl Apalutamide P450 , Androgen Receptor
N-Desmethyl-Apalutamide is a less potent antagonist of the androgen receptor, is an active Apalutamide metabolite.
T2499 Torcetrapib CP-529414 CETP
Torcetrapib (CP-529414) is a cholesteryl ester transfer protein (CETP) inhibitor that reduces the heterotypic transfer of cholesteryl ester from HDL to LDL and/or VLDL. Torcetrapib failed in phase III trials due to exces...
T10353 APX-115 free base Ewha-18278 free base NADPH-oxidase , NADPH
APX-115 free base (Ewha-18278 free base) (Ewha-18278 free base) is a potent, orally active pan NADPH oxidase (Nox) inhibitor (Kis: 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2, and Nox4). APX-115 effectively prevents kid...
T12372 PAT-505 EGFR
PAT-505 is an orally available, selective and potent inhibitor of autologous epidermal growth factor (IC50 2 nM in Hep3B cells, 9.7 nM in human blood, 62 nM in mouse plasma).
TP2124L Somatostatin 1-28 acetate Somatostatin 1-28 acetate(74315-46-1 Free base) Somatostatin
Somatostatin 1-28 acetate circulates in human plasma. Approximately 46% of the total somatostatin-like immunoreactivity in plasma is due to Somatostatin 1-28 acetate.
T60104 Mycophenolic acid-β-D-glucuronide solution Others
Mycophenolic acid glucuronide is the glucuronide metabolite of mycophenolic acid in human plasma.
T6999 Teneligliptin hydrobromide Teneligliptin hydrobromide anhydrous,MP-513 (hydrobromide) Others , Proteasome , DPP-4
Teneligliptin hydrobromide (MP-513 (hydrobromide)) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 ...
1 2 3 4 5 ... 26
TargetMol